Brian J. Isetts, PhD, BCPS, FAPhA

Professor, Department of Pharmaceutical Care & Health Systems
Brian J. Isetts

Contact

Office Address

7-125c Weaver-Densford Hall
308 Harvard St. SE
Minneapolis, MN 55455
United States

Titles

Professor, Department of Pharmaceutical Care & Health Systems
Affiliate Faculty, Institute for Health Informatics
Affiliate Faculty, PRIME Institute

Education

PhD, University of Minnesota (Social and Administrative Pharmacy), 1985

B. Sci. University of Wisconsin (Pharmacy) 1979

Fellowships

American Pharmacists Association, Academy of Pharmaceutical Research and Science. Pharmaceutical Clinical Scientist program, Kellogg Foundation Fellow

Licensures and Certifications

Board Certified Pharmacotherapy Specialist (BCPS)

Expand all

Biography

Bio

Brian Isetts is a Professor at the University of Minnesota College of Pharmacy and a pharmacist with over 25 years of experience working as a nursing home consultant, and in community and institutional practice. Dr. Isetts has distinguished himself as a Board Certified Pharmacotherapy Specialist to improve medication effectiveness and safety for patients of all ages. Brian received his undergraduate degree in pharmacy from the University of Wisconsin, and his PhD in Social and Administrative Pharmacy from the University of Minnesota.

At the national level, Dr. Isetts served as a Health Policy Fellow in the Centers for Medicare & Medicaid Services (CMS) in Washington, D.C. on a two-and-a-half year sabbatical working on improvements to the Medicare Part D Drug Program, and serving in the CMS Innovation Center to reduce adverse drug events and to study effective medication use in collaboration with national Person and Family Engagement (PFE) organizations.

Brian also serves as Pharmacy’s Primary Advisor to the American Medical Association’s (AMA) Current Procedural Terminology (CPT®) Editorial Panel working to recognize and report pharmacists’ medication therapy management (MTM) services within official CPT health reporting and billing nomenclature. In addition, he is the University of Minnesota College of Pharmacy’s investigator for the Geriatric Workforce Enhancement Program funded through a five-year grant from the Health Resources and Services Administration (HRSA). 

Expertise

  • Long-term care
  • Geriatric pharmacotherapy
  • Health policy research
  • Primary Representative for Pharmacy, American Medical Association, Current Procedural Terminology (CPT) Editorial Panel
  • Member, Workgroup 1-CPT Coding, Pharmacy Health Information Technology Collaborative
  • Member, Interprofessional Geriatrics Coordinating Council, University of Minnesota, Northstar Geriatrics Workforce Enhancement Program 

Awards & Recognition

  • Get the Medications Right (GTMRx) Institute Distinguished Fellow, 2019
  • APhA-Foundation Quality Center Pinnacle Award, 2016
  • Hubert H. Humphrey Award recognizing major contributions in government and/or legislative service, American Pharmacists Association, 2015
  • Peter P. Lamy Memorial Lecture Award, Signature research presentation,  2015
  • University of Minnesota College of Pharmacy, Samuel F. Melendy Lecture Award, 2013
  • University of Oklahoma Health Sciences Center, College of Pharmacy, Philip and Ethel Ashby Distinguished Lecture Award, 2007
  • Bowl of Hygeia Award, Minnesota Pharmacists Association, 2005
  • Jacob W. Miller Award, American Pharmacists Association-Foundation, 2005
  • Pinnacle Award – APhA-Foundation Quality Center, 2004

Professional Associations

  • American Pharmacists Association
  • Wisconsin Pharmacy Alumni Association
  • Minnesota Pharmacists Association
  • American Society of Consultant Pharmacists
  • American Pharmacists Association
  • American College of Clinical Pharmacy
  • American Association of Colleges of Pharmacy
  • American Society of Health-System Pharmacists

Research Summary

Dr. Isetts' field of expertise is in the scholarship of caring, specifically studying the outcomes of medication therapy management services provided in integrated, team-based care settings. Research interests focus on working with the person and family engagement (PFE) community empowering patients to improve confidence and shared decision-making in medication use.

  • Team-based health care
  • Patient-centered health homes
  • Accountable care organizations
  • Drug-related morbidity and mortality
  • Clinical decision support
  • Effectiveness of health care teams in redesigning the U.S. medication use system
  • Evaluation of pharmacists contributions to improving care transitions and reducing readmissions
  • The scholarship of learning in interprofessional education and practice

Research Methods/Techniques

Health policy analysis; Mixed methods qualitative research

Teaching

Teaching Areas

Foundations of Pharmaceutical Care; Geriatric Pharmacotherapy

Courses

Phar 6706; Phar 6971

Clinical Experience Statement

Dr. Isetts has 30 years of experience working in hospital, clinic, long-term care, and community pharmacy settings.

Publications

PubMed

  • Isetts BJ, Olson AW, Schommer JC. Reframing the medication experience in pharmacy using seminal concepts of patient-centered care - Implications for practice. Pharmacy: Journal of Pharmacy Education and Practice. 2021, Vol. 9, No. 9, doi.org/10.3390/pharmacy9010009.
  • Chabot M, and Isetts BJ. Interprofessional collaborations with Occupational Therapists and Pharmacists in alternative payment models. Spec Interest Sec Quart Practice Connections (supp OT Practice). Feb. 2020; Vol. 5:15-18. 
  • Clay PG, Burns AL, Isetts BJ, et al. PaCIR: A tool to enhance pharmacist patient care intervention reporting. J Am Pharm Assoc. 2019; 59:615-623. https://doi.org/10.1016/j.japh.2019.07.008.
  • Merkey B, Pittenger AL, Reidt S, Isetts BJ. Drug therapy problems in NCAA Division I-A Minnesota Gopher student-athletes. Innovations in Pharmacy, 2019;10(2):Article 6. https://doi.org/10.24926/iip.v10i2.1965.Isetts BJ. Integrating medication therapy management services provided by community pharmacists into a community-based accountable care organization. Pharmacy: Journal of Pharmacy Education and Practice. 2017;5(56); https://doi.org/10.3390/pharmacy5040056.
  • Olson AW, Isetts BJ, Kondic AM, Schommer JC. Comparing the research contributions of Community Pharmacy Foundation funding on practice innovation between non-academics and academics. Innovations in Pharmacy. 2017;8(3): Article 3.
  • Isetts BJ, Buffington DE, Carter BL, et. al.  Evaluation of pharmacist work in a collaborative model for hypertension. Pharmacotherapy, 2016; 36:374-84.
  • Isetts BJ, Brummel AR, Ramalho de Oliveira D, and Moen DW.Managing drug-related morbidity and mortality in a patient-centered medical home. Med Care. 2012: 50;997-1001.
  • Wagner D, Isetts BJ.Choosing to use the most powerful model in the world. Am J Hlth-syst Pharm. 2014: 71:1128-35.
  • Isetts BJ.Pharmaceutical care, MTM, & payment: past, present, & future.Ann Pharmacother. 2012: 46;S47-S56.
  • Isetts BJ.Engaging in rapid cycle innovation.Am J Pharm Educ.2012: 76 (3); Art. 37
  • Isetts BJ, Brummel A, Oliviera DR, Moen D. Integration of medication therapy management services into care system redesign. Minn. Phys. Showcase competition award. 2010; 9:20.
  • Cooke CE, Isetts BJ, Sullivan TE, Belletti D, and Fustgaard M. Potential value of electronic prescribing in health economic and outcomes research. Patient Rel. Outcome Meas. 2010; 1:1-16.
  • Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, Heaton AH, Wadd WB, Brown LB, and Cipolle RJ. Clinical and economic outcomes of medication therapy management services: The Minnesota experience. J Am Pharm Assoc. 2008; 48:203-11.
  • Isetts BJ, Buffington DE. CPT code-change proposal: National data on pharmacists' medication therapy management services. J Am Pharm Assoc. 2007; 47:491-95
  • Isetts BJ, Schondelmeyer SW, Heaton AH, Wadd WB, Hardie NA and Artz MB. Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life. Res Soc & Adm Pharm. 2006; 2:129-42.
  • Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med. 2003; 163:1813-20.

Grants

Health Resources and Services Administration; Community Pharmacy Foundation